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Demonstration and characterization of C3 receptors on rat glomerular
epithelial cells. Receptors for C3 have been demonstrated on the
glomerular podocyte in humans. There is conflicting evidence regarding
the presence of C3 receptors on rat glomerular cells. Even when shown
to be present, the ligand specificity of the receptor has not been
determined. Decapsulated rat glomeruli obtained from male Sprague-
—Dawley rats weighing 50 to 100 g were placed in enriched culture
media. On days four to eight, cells of epithelial morphology were
observed growing out of glomeruli. Receptors for C3 were detected by
rosette formation of sheep erythrocytes (E) coated with antibody (A)
and complement (EAC) around the glomerular epithelial cells in cul-
ture, The EACs were prepared by incubating antibody—coated sheep
erythrocytes with CS-deficient mouse serum or with individual compo-
nents of complement. Results indicate the presence of two types of C3
receptors on glomerular epithelial cells—CR1 for C3b and CR2 for C3d.
The functional roles of these receptors remain to be elucidated.
Human glomeruli have been shown to possess receptors for
the C3b and C3bi component of complement [1, 2]. The C3b
receptor has been localized to the visceral epithelial cell [31.
The existence of these receptors has implied that the glomerular
epithelial cells may somehow be involved in the uptake and
elimination of immune reactants which may localize to the
glomeruius. The presence of these receptors on glomeruli of
vertebrate species other than man is controversial. A number of
investigators have not been able to find C3 receptors on
glomeruli of a variety of animals including the rat [1, 41. Studies
of glomerular cells in culture have yielded conflicting results.
Whereas Kreisberg, Hoover and Karnovsky found C3 recep-
tors on rat glomerular epithelial cells [5], Foidart and associates
failed to do so [6]. We report the results of our studies of the
presence and ligand specificity of C3 receptors on rodent
glomerular cells in primary culture.
Methods
Rat glomeruli were grown in culture by the method of
Kreisberg, Hoover and Karnovsky [5]. Male Sprague—Dawley
rats (Harlan Sprague—Dawley, Wisconsin, USA) weighing ap-
proximately 50 to 100 g were anesthetized by intraperitoneal
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injection of sodium pentobarbital, 35 mg/kg body weight, sup-
plemented by ether, as needed. The kidneys were perfused via
the aorta using Hank's balanced salt solution (BSS).1 (Grand
Island Biological Co., Grand Island, New York, USA) at a
pressure of about 120 mm Hg in order to flush out formed
elements of blood from the renal circulation. The kidneys were
removed, bisected, and the cortex dissected out under sterile
conditions. The cortex was minced and serially passed through
sieves of mesh size 60, 150, and 200, respectively (W.S. Tyler
Inc., Mentor, Ohio, USA), while being generously rinsed with
Hank's BSS. The glomeruli were collected from the top of the
200-mesh sieve and washed repeatedly with Hank's BSS by
centrifugation at 100 x g for 10 minutes. When examined by
phase contrast microscopy and transmission electron micros-
copy, most of the glomeruli were decapsulated and tubular
fragments were rare. The isolated glomeruli were then placed in
the culture medium in multiple well culture dish (Corning, New
York, USA), at 37°C, in an atmosphere of 95% air and 5% CO2.
The culture medium was a composite of two media: (1) RPMI
1640 (KC Biological, Lenexa, Kansas, USA) containing 15 mM
Hepes, 20% fetal calf serum (heat inactivated), 0.66 U/mi of
insulin and antibiotics—penicillin 100 U/mi and streptomycin
100 sg/m1, and, (2) conditioned medium from 3T3 fibroblasts
(American Type Culture Collection, Rockville, Maryland,
USA) in log phase of growth comprising Dulbecco's modified
Eagle's medium and 10% fetal calf serum. The conditioned
medium from fibrobiasts was filtered with 0.22 r filter (Nalge,
Rochester, New York, USA) before use. The nutrient medium
was changed every third day.
Morphologic studies
Cultures were examined and photographed by phase contrast
microscopy (Nikon Diaphot, Tokyo, Japan).
l Abbreviationsused in this paper: Hank's BSS, Hank's balanced salt
solution; CR1, a type of C3 receptor that binds C3b and C4b; CR2, a
type of C3 receptor that binds C3bi and C3d; CR3, a type of C3 receptor
that binds C3bi, non-C3d; E, sheep erythrocytes; A, rabbit anti-sheep E
1gM antibody; C, ligands of complement such as C3b, C3d; GVBE,
gelatin veronal buffer with 0.01 M EDTA; GVB, gelatin veronal buffer;
GEC, glomerular epithelial cells.
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Fig. 1. Epithelial cells growing out of glomerulus on day six of primary culture. The glomerulus is in the center. The epithelial cells are tightly
packed. The cells have large nuclei, prominent nucleoli and granular cytoplasm (x360, phase contrast).
Scanning and transmission electron microscopy were per-
formed on cultures which were fixed for one hour in 2% wt/vol
paraformaldehyde and 2.5% glutaraldehyde in 0.1 M cacodylate
buffer, pH 7.4 [7]. The cultures were then washed and stored in
buffer.
For transmission electron microscopy, the glomeruli were
planted on plastic cover slips and after they were embedded in
plastic, the specimens were immersed in liquid nitrogen and
snapped off of the cover slips. The sections were re-embedded
in plastic and oriented so that the thin sections were cut
perpendicular to the original surface. Other cultures were
harvested from culture flasks following fixation, centrifuged,
and the button was embedded in plastic. Thin sections, cut with
diamond knives and mounted on 100- and 200-mesh grids, were
stained with uranyl acetate and lead citrate, and examined in an
electron microscope (Philips 301).
Scanning electron microscopy was performed on cultures
grown on coverslips. Following fixation, the cultures were
osmicated, rapidly dehydrated in alcohol, and changed to Freon
113 (DuPont, Wilmington, Delaware, USA) as the transitional
fluid. The cultures were critical point dried (Balzers CPD 020),
coated with gold (Pelco sputter coater 900C) and examined in a
scanning electron microscope at 15 KV (JEOL 35 smc, JEOL
Ltd., Tokyo, Japan).
Nonspecific esterase reaction was employed to detect possi-
ble presence of macrophages in primary culture. Immunofluo-
rescence using antibody to Factor VIII antigen (Dako Labs,
California, USA) was performed to detect the presence of
endothelial cells in culture.
Assays for C3 receptors
In humans, individual receptors for distinct ligands of C3
have been described: CR! binds C3b and C4b, CR2 binds C3bi
and C3d, and, CR3 binds C3bi, non-C3d [81. Receptors for C3
ligands on rat cells in vivo have not been described so far.
Assays were carried out in order to determine the presence of
CR! and CR2 receptors for different ligands of C3 on rat
glomerular cells in culture. These receptors were detected by
preparing sheep erythrocytes (E) coated with rabbit anti-sheep
erythrocyte 1gM antibody (A) and different ligands of C3 (C).
Thus EAC14b and EAC14b23b were prepared for the detection
of CR! and EAC(C5 deficient), and EAC3d for CR2. Estab-
lished, standard protocols of the assay were employed and
rosette formation with the coated sheep RBC (EAC) was used
as the index of the presence of C3 receptors [9].
Preparation of EA
Ten ml of sheep erythrocytes (E) in Alsever's solution
(Cordis, Miami, Florida, USA) were washed three times with
0.9 N saline at 450 xg at 4°C for 10 minutes. The buffy coat was
discarded and the sheep E were suspended in GVBE at 5%
vollvol. The sheep E were used within two weeks of purchase
and discarded if lysis was seen. The rabbit anti-sheep E 1gM
antibody (A) was diluted at 1:60 in 0.01 M GVBE as recom-
mended by the manufacturer (Cordis) and warmed to 37°C.
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Fig. 2. Scanning electron micrograph of glomerular epithelial cells on day seven of primary culture. The cells are flat and closely opposed with
numerous microvilli on the luminal surface of the cells (x 1800).
Equal volumes (6 ml) of the 5% sheep E suspension and 1:60
dilution of rabbit A were incubated together in a waterbath at
37°C for 30 minutes with gentle agitation, and transferred to an
ice bath for 30 minutes. The EA were washed in ice—cold 0,01
M GVBE once, in ice—cold gelatin verona! buffer (GVB) twice
and resuspended in GVB at a concentration of 2.5% (vol/vol).
The EA were warmed to 37°C in a water bath.
Preparation of EA coated with complement (EAC)
Human complement Cl, C2, C3 and C4 were commercially
purchased in the form of lyophilized powder (Cordis). They
were reconstituted with 5 ml of cold distilled water and con-
tained 50,000 CR50 units of Cl and 5,000 CR50 units of C2, C3
and C4 respectively.
Assays for CR1
CR1 was detected by using EAC14b and EACI4b23b which
were prepared as detailed below.
EACJ4b [9]. Ten ml of EA suspended at 2.5% (vol]vol) in
GVB and warmed to 37°C were mixed with 1.0 ml of Cl and
incubated at 37°C for 15 minutes. The EAC1 were washed twice
in GVB warmed to 37°C, using a room temperature centrifuge at
275 Xg for 10 minutes. The EACI were resuspended at 2.5%
(vollvol) in GVB warmed to 37°C and incubated with 1 ml of C4
at 37°C for 15 minutes. The GVB was maintained at 37°C when
using Cl to prevent loss of Cl that occurs below this tempera-
ture. The EACI4b were diluted in 50 ml of ice cold GYB and
washed twice by centrifugation at 275 x g for 10 minutes in a
room temperature centrifuge. The EAC l4b were resuspended
at 1% in PBS-BSA (vollvol) and stored at 0° to 4°C to be used
within two days.
EACJ4b23b (modified method of Burkholder et a! [4]).
EAC14b as prepared above were mixed with 1.0 ml each of
reconstituted human C2 and C3 in a single step and incubated at
37°C for 60 minutes. The EAC14b23b were washed x2 in GVB
at 275 xg for 10 minutes and resuspended at 1% in PBS-BSA.
Assays for CR2
CR2 was detected by employing EAC(C5 deficient) and
EAC3d which were prepared as follows.
EAC(5 deficient) [101. Blood collected from the CS-deficient
mice (strain DBA-2J, Jackson Laboratories, Bal Harbor,
Maine, USA) was centrifuged at 300 xg at 4°C for 10 minutes.
The serum was aliquoted in 0.19 ml volume and stored at
-70°C. The EA were incubated in equal volumes of 1.90 ml
with 1:10 dilution of the C5-deficient mouse serum (0.19 ml
serum diluted in 1.71 ml of GVB), at 37°C for 30 minutes. The
EAC(C5 del) were centrifuged at a low speed and washed twice
in GVB. The EAC(C5 del) in 0.01 ml were resuspended in 1.99
ml of Hank's BSS (0.5%) and stored at 0 to 4°C to be used
within one week. Due to the presence of C3 inactivators in the
mouse serum, mostly C3bi or C3d, rather than C3b, is deposited
on the EAC prepared by this method.
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Fig. 3. Transmission electron micrograph of glomerular epithelial cells in primary culture. Note the suggestion of a zonula occiudens (tightjunction) close to the apical surface of the cells (arrow) (X 170,000).
EAC3d. The EAC prepared with CS-deficient mouse serum
may carry C3bi predominantly [81. As C3bi can bind both CR2
and CR3, in order to detect CR2, EAC have to be prepared
containing C3d only, the specific ligand for CR2. To ensure that
the C3 present on EAC was in the form of C3d, the EAC(C5
det) were further treated with trypsin [9]. Three ml of EAC(C5
def) were incubated with 30 1.d of trypsin (100 ig/ml) at 37°C for
30 minutes, giving a final concentration of 1 p,g/ml of trypsin.
The EAC3d were washed three times with GVB and resus-
pended at 1% in PBS-BSA. The EAC3d were stored at 4°C and
used within two days. The EAC3d bind only to CR2 type of C3
receptor.
The EAC rosette assay using rat glomerular epithelial cells
The assay was performed with glomerular cells in primary
culture on days four to eight. The medium was aspirated and the
cell layer was washed twice in Hank's BSS. The EAC bound
with various ligands—EAC14b, EAC14b23b, EAC(CS def) and
EAC3d were layered over the cells and incubated for 60
minutes at 37°C in a moist chamber. Following incubation, the
cell layer was washed at least three times with PBS. The
rosettes were observed by both phase contrast microscopy and
scanning electron microscopy. A rosette was defined as binding
of at least three RBC to a cell. Each rosette assay was
performed on at least four individual primary glomerular culture
lines. In every primary culture, each individual C3 ligand was
incubated with a minimum of three wells (N = 12 for each C3
ligand).
The EAC rosette assays were performed employing a number
of controls. Human kidney biopsy material (glomeruli), human
erythrocytes (group 0), and human mononuclear cells in periph-
eral blood formed rosettes with EAC14b and EAC1423b and
were employed as "positive" controls for assays with these
ligands, as they are known to possess CR! receptor [81. The
human mononuclear cells were obtained by ficoll gradient
separation (Pharmacia, Piscataway, New Jersey, USA). The
rosette formation with the human erythrocytes was not as
numerous as with the other two positive controls, so that the
latter were more frequently used. Since these indicator cells did
not form rosettes with the Daudi lymphoblasts, they did not
have C3d on their surfaces. The Daudi lymphoblasts in culture
formed rosettes with EAC3bi and EAC3d, but not with CR!
ligands. Therefore they were used as "positive" control for
CR2. The Daudi cells are known to possess only CR2 receptors
and not CR! [9]. The mouse peritoneal macrophages formed
rosettes with EAC!4b, EAC1423b and EAC(C5 def) but not
with EAC3d; that is, they possessed CR! and CR3 receptors
and not CR2. Thus, they were used as "negative" control for
CR2 receptor (Gordon D. Ross, personal communication, [I !]).
These observations also demonstrated that the EAC3d indica-
tor cells do not have residual reactive C3b, C4b or C3bi on their
surfaces. As whole human C! (in the absence of serum) and not
purified Clq was used in the preparation of the ligands of CR!,
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Fig. 4. Mesangial—like cells during week four of primary glomerular
intercellular spaces (x360, phase contrast).
it is very unlikely that binding of the Cl containing ligands was
to a Clq receptor. Also, the method of preparation of EAC14b
and EACI423b differed considerably from that of EClq em-
ployed by others in the detection of Clq receptor. To study
whether EAC rosette formation was a nonspecific property of in
vitro cell culture conditions, a non-epithelial cell line, the
mouse 3T3-fibroblasts in culture was employed as control.
The glomerular cells were incubated with sheep erythrocytes
(E) alone in every experiment. Also, assay for C3 receptors was
performed under conditions of saturation of potential 1gM
binding sites on glomerular cells. This was done to distinguish
between rosette formation due to the presence of potential 1gM
binding sites and that due to the C3 receptor. The glomerular
cells in primary culture were first incubated with 1:60, 1:120
dilutions of rabbit anti-sheep erythrocyte 1gM antibody at 37°C
for 60 minutes. The cells were then washed twice with Hank's
BSS and EA, EACI4b, EAC1423b, EC(C5 del) and EAC3d
assays performed in the usual manner. The experiments were
performed on three separate series of primary glomerular
cultures, on days five, six and seven.
Results
Identification of glomerular cells in culture
Two types of cells were seen to grow from the glomeruli at
different times following planting of glomeruli in the culture
medium. On days four to five, large, polygonal, tightly packed
culture. Note the stellate shape, loose arrangement with abundant
cells with large nuclei and granular cytoplasm were seen
growing out of the parent glomerulus, as observed by phase
contrast microscopy (Fig. 1). By scanning electron microscopy,
these cells measured approximately 60 in diameter and had a
centrally located nucleus. They grew in sheets with closely
apposed cell borders and the luminal surface was covered with
numerous microvilli (Fig. 2). The cells were seen to grow in a
monolayer by transmission electron microscopy and there was
a complex pattern of lateral projections at the cell borders
which interdigitated with those of the adjacent cell. Close to the
apical surface the cells were joined at a junction suggestive of a
short zonula occludens (tight junction) (Fig. 3). The cytoplasm
was very attentuated at the periphery, and it contained few
organelles. In the perikaryon, there were well developed Golgi
bodies, rough endoplasmic reticulum and frequent, large sec-
ondary lysosomes which contained granular and membranous
debris. By morphology these cells appeared epithelial and will
be referred to as glomerular epithelial cells (GEC).
During the first week of primary culture, some cells which
stained positively with antibody to Factor VIII antigen were
seen, indicating the presence of endothelial cells. When non-
specific esterase reaction was performed, a few cells reacted
positively indicating the presence of monocyte—macrophagcs
also, However, endothelial cells and macrophages accounted
for a minority of the cell population.
During the second week of culture, the GEC were progres-
sively replaced by loosely arranged, stellate cells whtch became
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Fig. 5. Glomerular epithelial cells forming rosettes with EACJ4b indicating the presence of CR1 type of receptors. Sheep RBCs coated with 1gM
antibody and complement (14b) sharply delineate the margins of the colony of GEC (x364, phase contrast).
the predominant cell type by the third week (Fig. 4). These have
been referred to as the mesangial—like cells [5]. In order to
conduct experiments on the GEC only, the EAC rosette assays
were performed only between days four to eight.
Detection of CR1 and CR2 types of C3 receptors on GEC
using specific ligands
Demonstration of CR1. Both EAC14b and EAC14b23b
formed rosettes around GEC in primary culture (Fig. 5). The
evidence for the presence of CR1 was obtained using two
distinct ligands.—C3b and C4b. The sheep erythrocytes carrying
C3b also formed rosettes on human glomeruli on renal biopsy
(Fig. 6); whereas EAC14b and EAC14b23b formed rosettes
with human mononuclear cells. Human glomeruli and mononu-
clear cells are both known to have CR1 and were employed as
"positive" controls [81. However, when rat renal cortical tissue
was incubated with EAC14b and EAC14b23b no rosette forma-
tion was seen over the glomeruli or any other structures.
When examined by phase contrast microscopy, the binding of
C3b- or C4b-carrying sheep RBC to GEC was not uniform in a
given colony of cells. In general, in a given colony about 60% of
cells of epithelial morphology formed rosettes. The cells
towards the periphery of the GEC colony appeared to bind the
EAC more frequently than those towards the center, close to
the glomerulus. The sheep RBC appeared to surround borders
of individual GEC (Fig. 7). When examined by scanning elec.
tron microscopy, each GEC bound 15 to 30 sheep RBC which
were generally distributed around the surface of the cell (Fig.
8). No rosette formation was seen with cell fragments or debris
(Fig. 8) implying that an intact cell was necessary for binding to
the complement receptor.
Demonstration of CR2. The EAC(C5 del) and EAC3d (Fig. 9)
formed rosettes with the GEC in primary culture, thus provid-
ing evidence for the presence of CR2. Confirmation of ability of
EAC3d to bind only to CR2 type of receptor was obtained using
two controls. First, Daudi lymphoblasts which are known to
possess only CR2 receptor formed rosettes with EAC3d but not
with CR1 ligands. Second, mouse peritoneal macrophages
which possess CR! and CR3 receptors but not CR2, failed to
react with EAC3d; however, rosette formation was seen with
EAC14b, EAC1423b (ligands for CR1) and with EAC(C5 dee,
that is, EAC3bi (a ligand for CR3). The distribution and pattern
of binding of ligand carrying sheep erythrocytes to the GEC
were indistinguishable between CR! and CR2. The glomeruli on
biopsy of rat renal cortex did not bind with EAC(C5 del) or with
EAC3d.
The 1gM blocking experiment. When the GEC were incu-
bated with EA-IgM alone, adherence of RBCs was seen. To
demonstrate rosette formation due to C3 receptors as distinct
from that due to 1gM binding sites, the latter were presaturated
with 1:60 and 1: 120 dilutions of the rabbit anti-sheep E 1gM
antibody and rosette assays performed with EA, EAC!4b,
EAC!423b, EAC(C5 del) and EAC3d. Whereas EA failed to
bind to GEC following preincubation with 1gM, rosette forma-
tion by EAC!4b, EAC1423b (for CR1) and EAC(C5 del),
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Fig. 6. The EACJ423b have formed rosettes with a normal human glomerulus in a frozen section, The EAC did notbind to the tubulo-interstitium.
(x 364, phase contrast).
EAC3d (for CR2) was seen. These results were reproduced on
days five, six and seven of three separate lines of primary
glomerular cultures.
Free sheep erythrocytes did not bind GEC in any experiment.
In order to exclude rosette formation as a nonspecific property
of in vitro cell culture, a non-epithelial cell line, mouse 3T3
fibroblasts in culture were tested with sheep erythrocytes alone
(E) and with EACI4b, EACI4b23b, EAC(C5 def) and EAC3d.
No rosettes were detected with any of these particles.
Discussion
We have demonstrated the presence of CR1 and CR2 recep-
tors on glomerular epithelial cells in culture. As the rodent
glomerulus is a composite of several cell types, glomerular cells
in culture require precise identification. Four cell types can
potentially grow out of isolated, decapsulated glomeruli in
culture: mesangial cells, Ia positive monocytes [121, endothelial
cells, and visceral epithelial cells. Evidence that the cells which
we have employed to detect C3 receptors are glomerular
visceral epithelial cells includes the following: (i) the polygonal
shape of the cells, tightly packed arrangement with cobblestone
appearance of the cell monolayer; the presence of copious
microvilli and tight junctions are well accepted morphological
criteria for epithelia in culture [131. The mesangial cells [51,
endothelial cells [141, and monocytes [15] do not share these
morphological features when studied in culture. (ii) The epithe-
hal cells clearly proliferate and increase in number as duration
of culture is prolonged whereas monocytes are not known to
replicate in in vitro culture conditions [161. (iii) The epithelial
and mesangial cells are the predominant cell type at different
times in glomerular culture [5, 6]. Our observations confirm that
the cells are mostly epithelial during the first week, whereas
they are largely overgrown by mesangial cells by the third
week. This type of cell growth is in accordance with the mosaic
theory of growth of explanted tissue [171. Our experiments with
C3 receptors were conducted only between days four to eight
when the cell type was predominantly epithelial. (iv) Whereas
the human GEC possess C3 receptors there are important
differences in the expression of this receptor on other glomer-
ular cell types [181. The mesangial cells do not possess these
receptors [5, 6, 18]. Receptors for C3 have not been described
with unstimulated endothelial cells in culture, and the endothe-
hal cells are further characterized by the presence of factor VIII
antigen on their surface. The other glomerular cell type which
possesses C3 receptors is the monocyte and the GEC can be
distinguished from these cells on the basis of morphology
negative nonspecific esterase reaction and ability to proliferate
in culture. Even though monocytes and endothehial cells were
present in primary culture, numerically they formed a minority
of the total cell population and could not account for the
number of cells displaying rosettes (around 60% of total cell
number).
The existence of C3 receptors on cultured rat glomerular
epithelial cells has been controversial [5, 61. Our findings
confirm and extend the observations of Kreisberg, Hoover and
Karnovsky who were the first to demonstrate C3 receptors on
r.
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Fig. 7. The C3 ligand carrying sheep RBC surround each individual glomerular epithelial cell at the edge of a colony. The receptors appear to
be generally distributed along the cell borders (x 352, phase contrast).
Fig. 8. Scanning electron micrograph of a colony of GEC forming rosettes with EAC3bi, Note the rosettes restricted to cells and not binding to
cell debris (asterisks). The number of RBCs binding to each cell varies between 15 to 30 (x235). The inset shows higher magnification of an area
of an individual GEC binding C3 bound RBC. Note the microvilli (x3500).
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Fig. 9. The EAC'3d have formed rosettes with GEC on day five of primary culture (X400, phase contrast).
rat GEC in culture [5]. They described rosette formation with
EAC which were prepared using CS-deficient mouse serum as
the source of C3. As the form of C3 deposited on EAC by this
method maybe C3bi and/or C3d, and as C3bi can bind with both
CR2 and CR3 types of C3 receptors, the specific receptor
detected by these investigators is not clear. Thus, while C3
receptors were shown to be present on rat GEC in culture, the
nature and ligand specificity of these receptors remained un-
known. Foidart et al were unable to detect C3 receptors on
either of the two types of rat glomerular cells in culture 161.
They employed human or mouse serum as a source of C3. The
reasons for their inability to detect C3 receptors on cultured rat
GEC are not clear. The ability to demonstrate the C3 receptors
can depend upon the source of complement employed in the
assay. Striker, Killen and Farm have reported that C3b recep-
tors can be detected on human GEC in culture when fetal calf
serum is used as the source of complement, but not when the
complement source is pooled human serum 1181. The inability
of human serum to be used as a source of C3 ligands has been
attributed to the presence of C3 fragments which have been
shown to inhibit EAC rosette formation in other cell systems
[19].
By employing established protocols that deposit specific
ligands C4b and C3b on the indicator sheep erythrocytes, we
were able to demonstrate the presence of CR!. These ligands
have been used to detect CR1 on human glomeruli and human
mononuclear cells, both of which possess that receptor 181. In
addition, rosette formation with EAC3d demonstrated the CR2
receptor, which specifically binds the C3d fragment. Employ-
ment of appropriate "positive" control for CR2 (Daudi
lymphoblasts) and "negative" control (mouse peritoneal mac-
rophages) further confirmed the ability of ligands prepared
(EAC3d) to detect CR2. Adherence of EA-IgM to GEC was
observed and could represent a mixed agglutination reaction
rather than presence of receptor for 1gM, Shared antigens
between sheep RBC against which the 1gM antibody is directed
and rat GEC could lead to the same results as if Fc receptors for
1gM were present. Pre-incubation of GEC with 1gM resulted in
abolition of the adherence of EA-IgM to GEC indicating the
binding sites are saturable and C3 receptors demonstrable
following saturation.
Despite our own results and the reports of Kreisberg, Hoover
and Karnovsky [5], it has not been possible to similarly dem-
onstrate the receptors on intact rat glomeruli [1, 4]. We were
also unable to detect the receptors in glomeruli in frozen
sections of rat kidney biopsy, It appears that conditions that
exist in in vitro cell culture unmask or enhance the expression
of C3 receptors or may remove some in vivo inhibitory influ-
ence. Factors peculiar to in vitro culture may also have resulted
in the patchy distribution of the receptors in a given colony of
GEC. The distribution was more uniform when the individual
cells were examined, the receptors being circumferentially
located along the plasma membrane of the GEC. This is
consistent with the distribution of the CR! on individual human
GEC described by Kazatchkine et al [20]. C3 receptor expres-
sion is not a nonspecific property of culture conditions unre-
C3 receptors on glomerular epithelial cells 861
lated to the cell type. For example, C3 receptors are not present
on 3T3 fibroblasts in culture.
The presence of CR1 on cultured GEC implies that they are
capable of immune adherence. Because of their anatomic
location, it appears unlikely that GEC may participate in
trapping immune complexes circulating in glomerular capillar-
ies. The complement receptors may aid in the removal of
previously deposited, adjacent subepithelial immune com-
plexes. Several other functions have been attributed to CR! in
other cell systems, some of which may be relevant to GEC. The
CR1 is known to serve as a cofactor in the degradation of C3b
to C3bi by factor I [21], C3bi to C3dg [22] andpromote decay of
bound C4b [23]. It may thus perform an autoregulatory function
on events that follow the occupation of CR1 on GEC.
In an attempt to determine whether the density of C3 recep-
tors can relate to disease predisposition or severity, several
studies have tried to correlate the presence of C3-containing
immune complexes on human renal biopsies with the density of
C3 receptor, with conflicting results [20, 24—271. Some authors
have found decreased C3 receptor activity in diseases associ-
ated with subepithelial immune complex deposition, such as
membranous nephropathy [24—26]. Conceivably, the decreased
density of C3 receptors on GEC could predispose the
glomerulus to the development of subepithelial immune depos-
its because of a diminished ability of the GEC to carry out
receptor—specific endocytosis.
While there has been controversy in the literature regarding
the existence of C3 receptors in rodent glomeruli, our results
demonstrate the presence of both CR1 and CR2 receptors on
epithelial cells growing from rat glomeruli in primary culture.
Despite the difficulty demonstrating the C3 receptors in vivo,
the rodent GEC may be capable of expressing these functional
structures under appropriate in vivo conditions.
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